Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry

• Data on caplacizumab use for thrombotic thrombocytopenic purpura (TTP) in Italy are missing. • Twenty-six Italian patients were treated with caplacizumab for an acute immune TTP episode. • Caplacizumab was effective in treating acute TTP in the Italian real-world clinical setting. • Two major blee...

Descripción completa

Detalles Bibliográficos
Autores principales: Agosti, Pasquale, De Leo, Pasqualina, Capecchi, Marco, Ferrari, Barbara, Mancini, Ilaria, Gattillo, Salvatore, Trisolini, Silvia Maria, Rinaldi, Erminia, Podda, Gian Marco, Prezioso, Lucia, Salutari, Prassede, Facchini, Luca, Caramazza, Domenica, Tolomelli, Giulia, Artoni, Andrea, Peyvandi, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502422/
https://www.ncbi.nlm.nih.gov/pubmed/37720483
http://dx.doi.org/10.1016/j.rpth.2023.102185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502422/
https://www.ncbi.nlm.nih.gov/pubmed/37720483
http://dx.doi.org/10.1016/j.rpth.2023.102185

Ejemplares similares